Baxter International Inc (BAX)
34.19
-0.04
(-0.12%)
USD |
NYSE |
Apr 01, 11:15
Baxter International Enterprise Value: 28.93B for March 31, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 159.32B |
| Abbott Laboratories | 236.45B |
| Becton Dickinson & Co | 83.80B |
| West Pharmaceutical Services Inc | 15.91B |
| Alphatec Holdings Inc | 1.899B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -512.00M |
| Revenue (Quarterly) | 2.753B |
| Total Expenses (Quarterly) | 2.754B |
| EPS Diluted (Quarterly) | -1.00 |
| Gross Profit Margin (Quarterly) | 34.83% |
| Profit Margin (Quarterly) | -18.60% |
| Earnings Yield | -3.74% |
| Operating Earnings Yield | 3.26% |
| Normalized Earnings Yield | 0.3790 |